Browsing: 14.5B

Boston Scientific’s planned $14.5 billion acquisition of Penumbra started off the year with a bang. The two fast-growing, cardiovascular companies…

Dive Brief: Boston Scientific plans to acquire Penumbra for about $14.5 billion, the companies announced Thursday. Penumbra makes heart devices…